ANN ARBOR, Mich.--(BUSINESS WIRE)--SensiGen LLC, a biotechnology company focused on developing proprietary gene-based molecular diagnostics announced today that it has exercised its option to exclusively license an ultra-sensitive Human Papillomavirus – HPV detection test developed at the University of Michigan.
